These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 26982462)

  • 21. Dengue vaccines: challenges, development, current status and prospects.
    Ghosh A; Dar L
    Indian J Med Microbiol; 2015; 33(1):3-15. PubMed ID: 25559995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity and efficacy of flagellin-envelope fusion dengue vaccines in mice and monkeys.
    Liu G; Song L; Beasley DW; Putnak R; Parent J; Misczak J; Li H; Reiserova L; Liu X; Tian H; Liu W; Labonte D; Duan L; Kim Y; Travalent L; Wigington D; Weaver B; Tussey L
    Clin Vaccine Immunol; 2015 May; 22(5):516-25. PubMed ID: 25761459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?
    Valdés I; Lazo L; Hermida L; Guillén G; Gil L
    Front Immunol; 2019; 10():1956. PubMed ID: 31507591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Next-generation Dengue Vaccines: Leveraging Peptide-Based Immunogens and Advanced Nanoparticles as Delivery Platforms.
    Rahman NAA; Fuaad AAA; Azami NAM; Amin MCIM; Azmi F
    J Pharm Sci; 2024 Aug; 113(8):2044-2054. PubMed ID: 38761864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical and clinical development of a dengue recombinant subunit vaccine.
    Manoff SB; George SL; Bett AJ; Yelmene ML; Dhanasekaran G; Eggemeyer L; Sausser ML; Dubey SA; Casimiro DR; Clements DE; Martyak T; Pai V; Parks DE; Coller BA
    Vaccine; 2015 Dec; 33(50):7126-34. PubMed ID: 26458804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Historical discourse on the development of the live attenuated tetravalent dengue vaccine candidate TV003/TV005.
    Durbin AP
    Curr Opin Virol; 2020 Aug; 43():79-87. PubMed ID: 33164790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primates.
    Govindarajan D; Meschino S; Guan L; Clements DE; ter Meulen JH; Casimiro DR; Coller BA; Bett AJ
    Vaccine; 2015 Aug; 33(33):4105-16. PubMed ID: 26144900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenges for the formulation of a universal vaccine against dengue.
    Chokephaibulkit K; Perng GC
    Exp Biol Med (Maywood); 2013 May; 238(5):566-78. PubMed ID: 23856907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccines and immunization strategies for dengue prevention.
    Liu Y; Liu J; Cheng G
    Emerg Microbes Infect; 2016 Jul; 5(7):e77. PubMed ID: 27436365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection.
    Ali M; Pandey RK; Khatoon N; Narula A; Mishra A; Prajapati VK
    Sci Rep; 2017 Aug; 7(1):9232. PubMed ID: 28835708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dengue vaccine: hypotheses to understand CYD-TDV-induced protection.
    Guy B; Jackson N
    Nat Rev Microbiol; 2016 Jan; 14(1):45-54. PubMed ID: 26639777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Live attenuated vaccine: the first clinically approved dengue vaccine?
    Fink K; Shi PY
    Expert Rev Vaccines; 2014 Feb; 13(2):185-8. PubMed ID: 24350687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current issues in dengue vaccination.
    Thomas SJ; Endy TP
    Curr Opin Infect Dis; 2013 Oct; 26(5):429-34. PubMed ID: 23963259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of new vaccines against dengue fever and Japanese encephalitis.
    Kinney RM; Huang CY
    Intervirology; 2001; 44(2-3):176-97. PubMed ID: 11509879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dengue vaccine development: strategies and challenges.
    Ramakrishnan L; Pillai MR; Nair RR
    Viral Immunol; 2015 Mar; 28(2):76-84. PubMed ID: 25494228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospects for a dengue virus vaccine.
    Whitehead SS; Blaney JE; Durbin AP; Murphy BR
    Nat Rev Microbiol; 2007 Jul; 5(7):518-28. PubMed ID: 17558424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring dengue proteome to design an effective epitope-based vaccine against dengue virus.
    Sabetian S; Nezafat N; Dorosti H; Zarei M; Ghasemi Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2546-2563. PubMed ID: 30035699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction and preliminary investigation of a novel dengue serotype 4 chimeric virus using Japanese encephalitis vaccine strain SA14-14-2 as the backbone.
    Li Z; Yang H; Yang J; Lin H; Wang W; Liu L; Zhao Y; Liu L; Zeng X; Yu Y; Li Y
    Virus Res; 2014 Oct; 191():10-20. PubMed ID: 25091563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Next-generation dengue vaccines: novel strategies currently under development.
    Durbin AP; Whitehead SS
    Viruses; 2011 Oct; 3(10):1800-14. PubMed ID: 22069516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overview of plant-derived vaccine antigens: Dengue virus.
    Malabadi RB; Ganguly A; Silva JA; Parashar A; Suresh MR; Sunwoo H
    J Pharm Pharm Sci; 2011; 14(3):400-13. PubMed ID: 22202223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.